About: COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Sector: Healthcare
Industry: Medical Care Facilities
Latest price: $11.04 (-1.25%)
CMPS NASDAQ Compass Pathways Plc
Compass Pathways Plc share price
Atividade de preço de CMPS
Último preço
$ 11,040
Variação (24h)
-0,14 USD (1,25%)
Volume
625.33K
Volume (média 4 sem.)
-
Abertura
$ 11,25
Variação do dia
$ 10,94 - $ 11,36
Fechamento anterior
$ 11,18
Último negócio
26 Oct, 2:58 pm GMT+0
Atrasado
26 Oct, 2:58 pm GMT+0
CMPS price performance
Atrasado
26 Oct, 2:58 pm GMT+0
quote.marketSignals